Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Stephen Geisler"'
Autor:
Robert M. Bilder, Robert S. Goldman, Delbert Robinson, Gail Reiter, Lisa Bell, John A. Bates, Elizabeth Pappadopulos, Jose Maria J. Alvir, Margaret G. Woerner, Stephen Geisler, John M. Kane, David Geffen
Publikováno v:
Neuropsychological Trends, Vol 2, Pp 7-30 (2007)
Neuropsychological impairments are well documented in schizophrenia and are important targets of treatment. Information about the severity and pattern of deficits after treatment for the first psychotic episode and about relationships between these d
Externí odkaz:
https://doaj.org/article/1b6a4b0919c2417b84d43a10f249338a
Autor:
Pamela DeRosse, Todd Lencz, Anil K. Malhotra, Jian-Ping Zhang, Stephen Geisler, Evelyn J. Bromet
Publikováno v:
Schizophrenia Research. 146:285-288
Antipsychotic drugs are the mainstay of treatment for schizophrenia. However, a substantial proportion of patients are poorly responsive or resistant to first-line treatments, and clozapine treatment is often indicated. Therefore, we and others have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f6761522bfd8f5ed62c74ac65788818
https://doi.org/10.1016/j.schres.2013.01.020
https://doi.org/10.1016/j.schres.2013.01.020
Autor:
Jeffrey A. Lieberman, A. Koreen, Stephen Geisler, Jose Alvir, Brian B. Sheitman, Miranda Chakos, Margaret G. Woerner
Publikováno v:
Neuropsychopharmacology. 14:13S-21S
In studies conducted on largely treatment naive patients in their first episode of psychosis, we have found that treatment outcome is quite good and that most patients recover or at least achieve a substantial degree of symptom remission. However, ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80a422a8d21923ebb5005795b5b2104
https://doi.org/10.1016/0893-133x(95)00200-w
https://doi.org/10.1016/0893-133x(95)00200-w
Autor:
Jorge Ramos-Lorenzi, Thomas B. Cooper, Jeffrey A. Lieberman, Jose Alvir, John M. Kane, Stephen Geisler, Woerner M, Hana Novacenko
Publikováno v:
Neuropsychopharmacology. 11:107-118
Despite the proven efficacy of acute and maintenance pharmacotherapy in schizophrenia, practical methods for identifying patients who require continuous treatment to prevent relapse have not been established. We hypothesized that a pathologic overact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d212a5bcc09174a2fea61396794831b5
https://doi.org/10.1038/npp.1994.40
https://doi.org/10.1038/npp.1994.40
Autor:
Sally Szymanski, J.A. Lieberman, David Mayerhoff, Antony Loebel, J. Alvir, Stephen Geisler, Michael Borenstein
Publikováno v:
American Journal of Psychiatry. 151:1417-1422
Objective: The prevalence, clinical correlates, and outcome of the deficit syndrome were determined for 70 patients ascertained in their first episode of schizophrenia and then followed through their recovery. Method: Patients were treated in a stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2662af2ad1f4b4cbadaf22553cb41e08
https://doi.org/10.1176/ajp.151.10.1417
https://doi.org/10.1176/ajp.151.10.1417
Autor:
Jeffrey A. Lieberman, Jose Alvir, David Mayerhoff, Stephen Geisler, Antony Loebel, Sally Szymanski
Publikováno v:
American Journal of Psychiatry. 149:1183-1188
Objective; This study was undertaken to assess the potential effect ofduration of untreated illness on outcome in a group offirst-episode schizophrenic patients. Method: Seventy patients with schizophrenia diagnosed according to the Research Diagnost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1291506a4a2cdd07bb1e2aed39dbd2e6
https://doi.org/10.1176/ajp.149.9.1183
https://doi.org/10.1176/ajp.149.9.1183
Autor:
Deborah L. Levy, Woerner M, David Mayerhoff, G. Degreef, John M. Kane, Manzar Ashtari, Bernhard Bogerts, Michael Borenstein, Jose Alvir, Stephen Geisler, Antony Loebel, Miranda Chakos, Sally Szymanski, Jeffrey A. Lieberman, Robert M. Bilder, A. Koreen, Gregory A. Hinrichsen
Publikováno v:
Schizophrenia Bulletin. 18:351-371
Heterogeneity has been a consistent problem in the research and treatment of schizophrenia. Despite marked variation in the onset, phenomenology, treatment response and outcome of schizophrenic patients, our ability to identify subtypes is remarkably
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b43e11b0cb5613fdcdd0ede21b9c148
https://doi.org/10.1093/schbul/18.3.351
https://doi.org/10.1093/schbul/18.3.351
Autor:
David Mayerhoff, Lauren Lipschutz-Broch, Robert M. Bilder, Jeffrey A. Lieberman, G. Reiter, Stephen Geisler
Publikováno v:
Schizophrenia Bulletin. 18:437-448
The developmental processes leading to neuropsychological deficits in schizophrenia are poorly understood. Both early developmental defects and subsequent deterioration may occur. Intelligence test profiles are often used to estimate premorbid abilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6aa6de0b1f80f77672a4fb72c7e0a03
https://doi.org/10.1093/schbul/18.3.437
https://doi.org/10.1093/schbul/18.3.437
Autor:
John A. Bates, G. Reiter, Robert M. Bilder, John M. Kane, Robert Goldman, David Geffen, Elizabeth Pappadopulos, Lisa Bell, Woerner M, Delbert G. Robinson, Stephen Geisler, Jose Maria J. Alvir
Publikováno v:
Neuropsychological Trends, Vol 2, Pp 7-30 (2007)
Neuropsychological impairments are well documented in schizophrenia and are important targets of treatment. Information about the severity and pattern of deficits after treatment for the first psychotic episode and about relationships between these d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e94bbd63b71d85711621c7e4c9bf5ae
https://doi.org/10.7358/neur-2007-002-bild
https://doi.org/10.7358/neur-2007-002-bild
Autor:
Lisa Bell, Stephen Geisler, Elizabeth Pappadopulos, John A. Bates, Margaret G. Woerner, Deborah F. Willson, Jeffrey A. Lieberman, G. Reiter, Robert Goldman, John M. Kane, Jose Maria J. Alvir, Delbert Robinson, Robert M. Bilder
Publikováno v:
The American journal of psychiatry. 157(4)
Neuropsychological impairments are well documented in schizophrenia and are important targets of treatment. Information about the severity and pattern of deficits after treatment for the first psychotic episode and about relationships between these d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1666d1a002be98360b4ce8956748ff39
https://pubmed.ncbi.nlm.nih.gov/10739413
https://pubmed.ncbi.nlm.nih.gov/10739413